acquired
Stage
1
Investors
About
Transcend Therapeutics develops rapid-acting neuroplastic drugs targeting neuropsychiatric diseases such as PTSD, aiming to provide new treatment options for patients where current psychiatric medicines are ineffective.
Explore Transcend Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.